NEW YORK, July 31 – Exelixis of South San Francisco, Calif., has appointed Jeffrey Latts chief medical officer and senior vice president for clinical development.

The appointment comes as part of Exelixis plans to step up its drug discovery efforts and advances a newly acquired drug through clinical trials.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.